Status:
UNKNOWN
Sensitivity and Specificity of Xpert MTB/RIF Ultra
Lead Sponsor:
Assiut University
Conditions:
Tuberculosis
Eligibility:
All Genders
18-70 years
Brief Summary
To estimate diagnostic accuracy of Xpert Ultra and Xpert MTB/RIF for extrapulmonary tuberculosis and rifampicin resistance in adults suspected to be infected with mycobacterium tuberculosis. In additi...
Detailed Description
Xpert MTB/RIF was introduced recently and added great benefit in management of TB. Xpert MTB/RIF revolutionized the management of Mycobacterium tuberculosis (MTB) infections by providing faster and mo...
Eligibility Criteria
Inclusion
- \- Patients presented to Chest Department with suspected pulmonary or extrapulmonary Tuberculosis will be sequentially included
Exclusion
- Age: less than 18 years. Patients who received anti tuberculous drugs in the past 6 months. Unstable patients or need for ICU admission
Key Trial Info
Start Date :
December 11 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 25 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06058065
Start Date
December 11 2023
End Date
December 25 2024
Last Update
October 4 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.